Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2018 $ 4,926 $ 1 $ 10,186 [1]   $ 31 $ (5,292)
Beginning balance, shares at Dec. 31, 2018   10,687,106        
Net income (loss) (1,869)         (1,869)
Other comprehensive income (loss) 987       987  
Ending balance at Sep. 30, 2019 [1] 4,044 $ 1 10,186   1,018 (7,161)
Ending balance, shares at Sep. 30, 2019 [1]   10,687,106        
Beginning balance at Jun. 30, 2019 2,589 $ 1 10,186 [1]   375 (7,973)
Beginning balance, shares at Jun. 30, 2019   10,687,106        
Net income (loss) 812         812
Other comprehensive income (loss) 643       643  
Ending balance at Sep. 30, 2019 [1] 4,044 $ 1 10,186   1,018 (7,161)
Ending balance, shares at Sep. 30, 2019 [1]   10,687,106        
Beginning balance at Dec. 31, 2019 (38,774) $ 2 2,143   74 (40,993)
Beginning balance, shares at Dec. 31, 2019   19,977,113        
Common stock repurchased in connection with forward share purchase agreements     30,431 $ (30,431)    
Common stock repurchased in connection with forward share purchase agreements, shares   (2,798,058)   2,798,058    
Change in forward share purchase agreement liability 1,671   1,671      
Stock-based compensation (RSUs) 15,756   15,756      
Stock-based compensation (RSUs), shares   189,104        
Proceeds from issuance of common stock in public offering, net of issuance costs 36,152 $ 1 36,151      
Proceeds from issuance of common stock in public offering, net of issuance costs, shares   8,762,694        
Common stock issued to sellers (Earn-out 2019), shares   1,763,633        
Common stock issued to settle a payable [2],[3] 3,422   3,422      
Common stock issued to settle a payable, shares [2],[3]   580,595        
Net income (loss) (22,284)         (22,284)
Other comprehensive income (loss) (1,807)       (1,807)  
Ending balance at Sep. 30, 2020 (5,864) $ 3 89,574 $ (30,431) (1,733) (63,277)
Ending balance, shares at Sep. 30, 2020   28,475,081   2,798,058    
Beginning balance at Jun. 30, 2020 (8,990) $ 3 74,284 $ (24,218) (1,115) (57,944)
Beginning balance, shares at Jun. 30, 2020   27,999,713   2,258,510    
Common stock repurchased in connection with forward share purchase agreements     6,213 $ (6,213)    
Common stock repurchased in connection with forward share purchase agreements, shares   (539,548)   539,548    
Stock-based compensation (RSUs) 4,922   4,922      
Stock-based compensation (RSUs), shares   30,000        
Proceeds from issuance of common stock in public offering, net of issuance costs 4,155   4,155      
Proceeds from issuance of common stock in public offering, net of issuance costs, shares   984,916        
Net income (loss) (5,333)         (5,333)
Other comprehensive income (loss) (618)       (618)  
Ending balance at Sep. 30, 2020 $ (5,864) $ 3 $ 89,574 $ (30,431) $ (1,733) $ (63,277)
Ending balance, shares at Sep. 30, 2020   28,475,081   2,798,058    
[1] Amounts as of September 30, 2019 and before that date were retrospectively adjusted as a result of the accounting for the Business Combination (as defined in the notes). Specifically, the number of common shares outstanding during periods before the Business Combination are computed on the basis of the number of common shares of Kaleyra S.p.A. (accounting acquiror) during those periods multiplied by the exchange ratio established in the stock purchase agreement. Common stock and additional paid-in capital were adjusted accordingly.
[2] On March 6, 2020, the Company issued to Northland Securities Inc. (“Northland”), 140,000 shares of the Company’s common stock as a partial settlement of the amounts owned to Northland for financial advisory services provided by Northland to Kaleyra S.p.A. in connection with the previously consummated Business Combination.
[3] On May 1, 2020, the Company issued to Cowen Investments II LLC (“Cowen”) and Chardan Capital Markets, LLC (“Chardan”) an aggregate of 440,595 shares of the Company’s common stock (“Settlement Shares”), consisting of 374,506 Settlement Shares issued to Cowen, and 66,089 Settlement Shares issued to Chardan, as a partial settlement of the amounts owed to Cowen and Chardan for financial advisory services provided by Cowen and Chardan to Kaleyra S.p.A. in connection with the previously consummated Business Combination.